Cardiovascular disease more prevalent in lean vs. overweight, obese patients with NAFLD

Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing.“NAFLD in lean individuals is not a benign disease,” Karn Wijarnpreecha, MD, MPH, a transplant hepatology fellow at the University of Michigan, told Healio. “Attention to cardiac risk stratification and intervention is warranted for lean patients with NAFLD,”In a retrospective study conducted from 2012 to 2021, Wijarnpreecha andRead More

Related Articles